Retailers Accelerate Hiring Amid Cautious Consumer Outlook
Wall Street Remains Cautious on Snap Inc PostQ1 Results Amid Advertising Headwinds
Bernstein Sees Up to 40 Upside Potential in Six Indian Pharma Stocks
Oura Health Files Confidentially for IPO Signaling Potential Public Listing for Smart Ring Maker
Chinas Worst Mining Disaster in Over a Decade Claims 82 Lives at Liushenyu Mine Implications for Coal Sector Safety
Traders on Prediction Markets See Rising Odds of Federal Reserve Rate Hike by Mid2027
SNTI Q1 2026 Earnings NarrowerThanExpected Loss Cautiously Lifts Shares
authID Inc AUID Q1 2026 Earnings Narrowing Losses as Biometric Platform Gains Traction
VSTS Q1 2026 Earnings EPS Surges 89 Above Estimates Stock Gains
Victory Capital Holdings Inc VCTR Q1 2026 Earnings EPS Tops Estimates as Asset Manager Delivers Solid Profit Performance
ORGO Q1 2026 Earnings Significant EPS Miss Raises Concerns
CMS Q1 2026 Earnings Slight EPS Beat Amid Steady Utility Operations
MarisTech Ltd Warrants MTEKW Hold Steady at 016 Navigating Support and Resistance Levels
OYSE Hovers Near Trust Value as Slight Dip Reflects Cautious Trading
Fair Isaac FICO Rallies 171 as Stock Tests Key Resistance Levels
SailPoint Inc SAIL Surges Over 4 as Shares Approach Resistance Level
Globus Maritime GLBS Nears Support After 195 Decline Key Levels for Traders to Monitor
Labor Market Cools but Remains Resilient What to Expect from April Jobs Report
RCAT Q1 2026 Earnings Negative EPS Surprise as Strategic Initiatives Continue
Travelers TRV Holds Steady Near Support as Market Awaits Catalysts
FB Bancorp Inc FBLA Holds Steady at 1402 as Traders Await Catalyst
Axogen Inc AXGN Shows Mild Pullback Near Resistance Consolidation Possible
Rithm Acquisition Corp RAC Holds Steady at 1042 as SPAC Trading Remains Quiet
Blackbaud BLKB Stock Bounces Testing Resistance Near 3147 After 118 Gain
Crane Harbor Acquisition Corp II Rights CRANR Holds Steady at 022 as Trading Remains Muted
Gores Holdings X GTEN Edges Higher Testing Resistance at 1088 After Modest Gain
Alzamend Neuro ALZN Slides 174 as Stock Tests Key Support at 107